Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatment

Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatment

Background and objectivesThe standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC) includes androgen deprivation therapy (ADT), novel antihormonal therapies (NHT) and/or chemotherapy. Patients with newly diagnosed oligometastatic prostate cancer (omPCa) represent a...

Full description

Saved in:
Bibliographic Details
Main Authors: Viktoria Schütz, Christopher-Leo Nessler, Anette Duensing, Stefanie Zschäbitz, Dirk Jäger, Jürgen Debus, Markus Hohenfellner, Stefan Duensing
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Oncology
Subjects:
oligometastatic prostate cancer
radical prostatectomy
multimodal treatment
intensified treatment
prostate cancer
hormone sensitive prostate cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1475914/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1475914/full

Similar Items